Notably, we predicted K6 as the SUMOylation site of FoxA1 with high probability, suggesting that FoxA1 SUMOylation might be implicated in NAFLD pathogenesis. This evidence concerns the gene FOXA1 and metabolic dysfunction-associated steatotic liver disease.